Similasan Fliess-Schnupfen, Globuli

7680506720430 CH-50672 Globuli
Similasan Fliess-Schnupfen, Globuli
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
15
Selling units
15
Measure
g
Galenic form
Globuli
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/06/2022
Patient information leaflet
Français
24/06/2022
Patient information leaflet
Italien
24/06/2022

Detailed composition

Substance Quantity Type Category
allium cepa (HAB)
8.5 MG Substance Wirkstoff (Principe actif)
allium cepa (HAB)
1.0 MG Substance Wirkstoff (Principe actif)
allium cepa (HAB)
0.5 MG Substance Wirkstoff (Principe actif)
calcii carbonas
- Substance HNIDK
xylitolum
- Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50672
Drug name
Similasan Fliess-Schnupfen, Globuli
Galenic form
GLO
Authorization status
Z
Dispensing category
D
First authorization
17/10/1991
Authorization expiration date
31/12/9999
IT Number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Erkältungsschnupfen, allergischem Schnupfen, Heuschnupfen und nervösem Schnupfen mit reichlicher, wundmachender, wässriger Absonderung; Triefendem Schnupfen mit Tränenfluss, wunden Nasenlöchern

Package details

Description (FR)
SIMILASAN Rhume liquide glob 15 g
Description (DE)
SIMILASAN Fliess-Schnupfen Glob 15 g
Market launch
17/10/1991
Narcotic (BTM)
No

Other package sizes (3)

SIMILASAN rhume liquide glob (ancien) 15 g
None None
GTIN: 7680506720348
Not in V1
None
None None
GTIN: None
Not in V1
None
4.5 G
GTIN: None
Not in V1
Buy us a coffee Explore the data